Monitoring of β-amyloid dynamics after human traumatic brain injury

Journal of Neurotrauma

Volumn 31, Issue 1, 2014, Pages 42-55

  Marklund, Niklas ^a,e   Farrokhnia, Nina ^a   Hånell, Anders ^a   Vanmechelen, Eugeen ^b   Enblad, Per ^a   Zetterberg, Henrik ^c,d   Blennow, Kaj ^c   Hillered, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ADX NEUROSCIENCES   (Belgium)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

A ; APP; axonal injury; cerebral MD; energy metabolism; TBI

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DIFFUSE AXONAL INJURY; ENERGY METABOLISM; FEMALE; HUMAN; HYDROSTATIC PRESSURE; INTERSTITIAL FLUID; INTRACRANIAL PRESSURE; MALE; MICRODIALYSIS; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; TRAUMATIC BRAIN INJURY; VENTILATED PATIENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; BRAIN INJURIES; DIFFUSE AXONAL INJURY; FEMALE; HUMANS; MALE; MICRODIALYSIS; MIDDLE AGED; PEPTIDE FRAGMENTS; YOUNG ADULT;

EID: 84892698570     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.2964     Document Type: Article

References (88)

1. Selassie, A.W., Zaloshnja, E., Langlois, J.A., Miller, T., Jones, P., and Steiner, C. (2008). Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J. Head Trauma Rehabil. 23, 123-131.
2. McAllister, T.W. (2011). Neurobiological consequences of traumatic brain injury. Dialogues Clin. Neurosci. 13, 287-300.
3. Zetterberg, H., Hietala, M.A., Jonsson, M., Andreasen, N., Styrud, E., Karlsson, I., Edman, A., Popa, C., Rasulzada, A., Wahlund, L.O., Mehta, P.D., Rosengren, L., Blennow, K., and Wallin, A. (2006). Neurochemical aftermath of amateur boxing. Arch. Neurol. 63, 1277-1280.
4. Mckee, A.C., Stein, T.D., Nowinski, C.J., Stern, R.A., Daneshvar, D.H., Alvarez, V.E., Lee, H.S., Hall, G., Wojtowicz, S.M., Baugh, C.M., Riley, D.O., Kubilus, C.A., Cormier, K.A., Jacobs, M.A., Martin, B.R., Abraham, C.R., Ikezu, T., Reichard, R.R., Wolozin, B.L., Budson, A.E., Goldstein, L.E., Kowall, N.W., and Cantu, R.C. (2013). The spectrum of disease in chronic traumatic encephalopathy. Brain 136, 43-64.
5. Johnson, V.E., Stewart, W., and Smith, D.H. (2010). Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease? Nat. Rev. Neurosci. 11, 361-370.
6. Plassman, B.L., Havlik, R.J., Steffens, D.C., Helms, M.J., Newman, T.N., Drosdick, D., Phillips, C., Gau, B.A., Welsh-Bohmer, K.A., Burke, J.R., Guralnik, J.M., and Breitner, J.C. (2000). Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55, 1158-1166.
7. Clinton, J., Ambler, M.W., and Roberts, G.W. (1991). Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuro-pathol. Appl. Neurobiol. 17, 69-74.
8. Mortimer, J.A., Van Duijn, C.M., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., Kokmen, E., Kondo, K., Rocca, W.A., et al. (1991). Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20, Suppl. 2, S28-35.
9. Guo, Z., Cupples, L.A., Kurz, A., Auerbach, S.H., Volicer, L., Chui, H., Green, R.C., Sadovnick, A.D., Duara, R., DeCarli, C., Johnson, K., Go, R.C., Growdon, J.H., Haines, J.L., Kukull, W.A., and Farrer, L.A. (2000). Head injury and the risk of AD in the MIRAGE study. Neurology 54, 1316-1323.
10. Mayeux, R., Ottman, R., Tang, M.X., Noboa-Bauza, L., Marder, K., Gurland, B., and Stern, Y. (1993). Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501.
11. DeKosky, S.T., Abrahamson, E.E., Ciallella, J.R., Paljug, W.R., Wisniewski, S.R., Clark, R.S., and Ikonomovic, M.D. (2007). Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch. Neurol. 64, 541-544.
12. Ikonomovic, M.D., Uryu, K., Abrahamson, E.E., Ciallella, J.R., Tro-janowski, J.Q., Lee, V.M., Clark, R.S., Marion, D.W., Wisniewski, S.R., and DeKosky, S.T. (2004). Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 190, 192-203.
13. Li, J., Li, X.Y., Feng, D.F., and Pan, D.C. (2010) Biomarkers associated with diffuse traumatic axonal injury: exploring pathogenesis, early diagnosis, and prognosis. J. Trauma 69, 1610-1618.
14. Smith, D.H., Chen, X.H., Iwata, A., and Graham, D.I. (2003). Amyloid beta accumulation in axons after traumatic brain injury in humans. J. Neurosurg. 98, 1072-1077.
15. Lewen, A., Li, G.L., Olsson, Y., and Hillered, L. (1996). Changes in microtubule-associated protein 2 and amyloid precursor protein im-munoreactivity following traumatic brain injury in rat: influence of MK-801 treatment. Brain Res. 719, 161-171.
16. Pierce, J.E., Trojanowski, J.Q., Graham, D.I., Smith, D.H., and McIntosh, T.K. (1996). Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J. Neurosci. 16, 1083-1090.
17. Nunan, J., and Small, D.H. (2000). Regulation of APP cleavage by alpha-, beta and gamma-secretases. FEBS Lett. 483, 6-10.
18. Masters, C.L., Cappai, R., Barnham, K.J., and Villemagne, V.L. (2006). Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J. Neurochem. 97, 1700-1725.
19. Blennow, K., de Leon, M.J., and Zetterberg, H. (2006). Alzheimer's disease. Lancet 368, 387-403.
20. Price, D.L., Sisodia, S.S., and Gandy, S.E. (1995). Amyloid beta amyloidosis in Alzheimer's disease. Curr. Opin. Neurol. 8, 268-274.
21. Chen, X.H., Johnson, V.E., Uryu, K., Trojanowski, J.Q., and Smith, D.H. (2009). A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol. 19, 214-223.
22. Chen, X.H., Siman, R., Iwata, A., Meaney, D.F., Trojanowski, J.Q., and Smith, D.H. (2004). Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am. J. Pathol. 165, 357-371.
23. Cirrito, J.R., Yamada, K.A., Finn, M.B., Sloviter, R.S., Bales, K.R., May, P.C., Schoepp, D.D., Paul, S.M., Mennerick, S., and Holtzman, D.M. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922.
24. Loane, D.J., Pocivavsek, A., Moussa, C.E., Thompson, R., Matsuoka, Y., Faden, A.I., Rebeck, G.W., and Burns, M.P. (2009). Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat. Med. 15, 377-379.
25. Marklund, N., Blennow, K., Zetterberg, H., Ronne-Engstrom, E., Enblad, P., and Hillered, L. (2009). Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. J. Neurosurg. 110, 1227-1237.
26. Brody, D.L., Magnoni, S., Schwetye, K.E., Spinner, M.L., Esparza, T.J., Stocchetti, N., Zipfel, G.J., and Holtzman, D.M. (2008). Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224.
27. Graham, D.I., Adams, J.H., and Doyle, D. (1978). Ischaemic brain damage in fatal non-missile head injuries. J. Neurol. Sci. 39, 213-234.
28. Enblad, P., Frykholm, P., Valtysson, J., Silander, H.C., Andersson, J., Fasth, K.J., Watanabe, Y., Langstrom, B., Hillered, L., and Persson, L. (2001). Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke 32, 1574-1580.
29. Hutchinson, P.J., Gupta, A.K., Fryer, T.F., Al-Rawi, P.G., Chatfield, D.A., Coles, J.P., O'Connell, M.T., Kett-White, R., Minhas, P.S., Aigbirhio, F.I., Clark, J.C., Kirkpatrick, P.J., Menon, D.K., and Pickard, J.D. (2002). Correlation between cerebral blood flow, substrate delivery, and metabolism in head injury: a combined mi-crodialysis and triple oxygen positron emission tomography study. J. Cereb. Blood Flow Metab. 22, 735-745.
30. Hillered, L., Persson, L., Nilsson, P., Ronne-Engstrom, E., and Enblad, P. (2006). Continuous monitoring of cerebral metabolism in traumatic brain injury: a focus on cerebral microdialysis. Curr. Opin. Crit. Care 12, 112-118.
31. Hillered, L., Vespa, P.M., and Hovda, D.A. (2005). Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J. Neurotrauma 22, 3-41.
32. Bellander, B.M., Cantais, E., Enblad, P., Hutchinson, P., Nordstrom, C.H., Robertson, C., Sahuquillo, J., Smith, M., Stocchetti, N., Un-gerstedt, U., Unterberg, A., and Olsen, N.V. (2004). Consensus meeting on microdialysis in neurointensive care. Intensive Care Med. 30, 2166-2169.
33. Timofeev, I., Carpenter, K.L., Nortje, J., Al-Rawi, P.G., O'Connell, M.T., Czosnyka, M., Smielewski, P., Pickard, J.D., Menon, D.K., Kirkpatrick, P.J., Gupta, A.K., and Hutchinson, P.J. (2011). Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain 134, 484-494.
34. Badan, I., Dina, I., Buchhold, B., Suofu, Y., Walker, L., Gratz, M., Platt, D., Kessler, C.H., and Popa-Wagner, A. (2004). Accelerated accumulation of N-and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. Eur. J. Neurosci. 19, 2270-2280.
35. Yam, P.S., Takasago, T., Dewar, D., Graham, D.I., and McCulloch, J. (1997). Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion. Brain Res. 760, 150-157.
36. Wen, Y., Onyewuchi, O., Yang, S., Liu, R., and Simpkins, J.W. (2004). Increasebeta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res. 1009, 1-8.
37. Koike, M.A., Green, K.N., Blurton-Jones, M., and Laferla, F.M. (2010). Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am. J. Pathol. 177, 300-310.
38. Wang, X., Xing, A., Xu, C., Cai, Q., Liu, H., and Li, L. (2010). Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloidbeta oligomerization in rats. J. Alz-heimers Dis. 21, 813-822.
39. Qi, J.P., Wu, H., Yang, Y., Wang, D.D., Chen, Y.X., Gu, Y.H., and Liu, T. (2007). Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus. J. Alzheimers Dis. 12, 335-341.
40. Wisniewski, H.M., and Maslinska, D. (1996). Beta-protein immuno-reactivity in the human brain after cardiac arrest. Folia Neuropathol. 34, 65-71.
41. Zetterberg, H., Mortberg, E., Song, L., Chang, L., Provuncher, G.K., Patel, P.P., Ferrell, E., Fournier, D.R., Kan, C.W., Campbell, T.G., Meyer, R., Rivnak, A.J., Pink, B.A., Minnehan, K.A., Piech, T., Rissin, D.M., Duffy, D.C., Rubertsson, S., Wilson, D.H., and Blen-now, K. (2011). Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid beta levels in humans. PLoS One 6, e28263.
42. Claeysen, S., Cochet, M., Donneger, R., Dumuis, A., Bockaert, J., and Giannoni, P. (2012). Alzheimer culprits: cellular crossroads and interplay. Cell Signal 24, 1831-1840.
43. Koffie, R.M., Hashimoto, T., Tai, H.C., Kay, K.R., Serrano-Pozo, A., Joyner, D., Hou, S., Kopeikina, K.J., Frosch, M.P., Lee, V.M., Holtzman, D.M., Hyman, B.T., and Spires-Jones, T.L. (2012). Apo-lipoprotein E4 effects in Alzheimer's disease are mediated by sy-naptotoxic oligomeric amyloid-beta. Brain 135, 2155-2168.
44. Texido, L., Hernandez, S., Martin-Satue, M., Povedano, M., Casa-novas, A., Esquerda, J., Marsal, J., and Solsona, C. (2011). Sera from amyotrophic lateral sclerosis patients induce the non-canonical activation of NMDA receptors "in vitro". Neurochem. Int. 59, 954-964.
45. Magnoni, S., Esparza, T.J., Conte, V., Carbonara, M., Carrabba, G., Holtzman, D.M., Zipfel, G.J., Stocchetti, N., and Brody, D.L. (2012). Tau elevations in the brain extracellular space correlate with reduced amyloid-beta levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain 135, 1268-1280.
46. Skoglund, K., Enblad, P., and Marklund, N. (2009). Effects of the neurological wake-up test on intracranial pressure and cerebral per-fusion pressure in brain-injured patients. Neurocrit. Care 11, 135-142.
47. Elf, K., Nilsson, P., and Enblad, P. (2002). Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care. Crit. Care Med. 30, 2129-2134.
48. Osler, T., Baker, S.P., and Long, W. (1997). A modification of the injury severity score that both improves accuracy and simplifies scoring. J. Trauma 43, 922-925.
49. Wilson, J.T., Pettigrew, L.E., and Teasdale, G.M. (1998). Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J. Neurotrauma 15, 573-585.
50. Servadei, F., Murray, G.D., Penny, K., Teasdale, G.M., Dearden, M., Iannotti, F., Lapierre, F., Maas, A.J., Karimi, A., Ohman, J., Persson, L., Stocchetti, N., Trojanowski, T., and Unterberg, A. (2000). The value of the "worst" computed tomographic scan in clinical studies of moderate and severe head injury. European Brain Injury Consortium. Neurosurgery 46, 70-75.
51. Marshall, L.F., Marshall, S.B., Klauber, M.R., Van Berkum Clark, M., Eisenberg, H., Jane, J.A., Luerssen, T.G., Marmarou, A., and Foulkes, M.A. (1992). The diagnosis of head injury requires a classification based on computed axial tomography. J. Neurotrauma 9, Suppl. 1, S287-292.
52. Ronne-Engstrom, E., Cesarini, K.G., Enblad, P., Hesselager, G., Marklund, N., Nilsson, P., Salci, K., Persson, L., and Hillered, L. (2001). Intracerebral microdialysis in neurointensive care: the use of urea as an endogenous reference compound. J. Neurosurg. 94, 397-402.
53. Schulz, M.K., Wang, L.P., Tange, M., and Bjerre, P. (2000). Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 93, 808-814.
54. Reinstrup, P., Stahl, N., Mellergard, P., Uski, T., Ungerstedt, U., and Nordstrom, C.H. (2000). Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 47, 701-709.
55. Hansson, O., Zetterberg, H., Vanmechelen, E., Vanderstichele, H., Andreasson, U., Londos, E., Wallin, A., Minthon, L., and Blennow, K. (2010). Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol. Aging 31, 357-367.
56. Roberts, G.W., Gentleman, S.M., Lynch, A., Murray, L., Landon, M., and Graham, D.I. (1994). Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 57, 419-425.
57. Johnson, V.E., Stewart, W., and Smith, D.H. (2012). Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 22, 142-149.
58. Smith, D.H., Chen, X.H., Nonaka, M., Trojanowski, J.Q., Lee, V.M., Saatman, K.E., Leoni, M.J., Xu, B.N., Wolf, J.A., and Meaney, D.F. (1999). Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J. Neuropathol. Exp. Neurol. 58, 982-992.
59. Uryu, K., Chen, X.H., Martinez, D., Browne, K.D., Johnson, V.E., Graham, D.I., Lee, V.M., Trojanowski, J.Q., and Smith, D.H. (2007). Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp. Neurol. 208, 185-192.
60. Olsson, A., Csajbok, L., Ost, M., Hoglund, K., Nylen, K., Rosengren, L., Nellgard, B., and Blennow, K. (2004). Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebro-spinal fluid after severe traumatic brain injury. J. Neurol. 251, 870-876.
61. Lagares A, Ramos A, Pérez-Nuñez A, Ballenilla F, Alday R, Gómez PA, Kaen A, Lobato RD. (2009). The role of MR imaging in assessing prognosis after severe and moderate head injury. Acta Neurochir. (Wien) 151, 341-356.
62. Haacke, E.M., Duhaime, A.C., Gean, A.D., Riedy, G., Wintermark, M., Mukherjee, P., Brody, D.L., DeGraba, T., Duncan, T.D., Elovic, E., Hurley, R., Latour, L., Smirniotopoulos, J.G., and Smith, D.H. (2010). Common data elements in radiologic imaging of traumatic brain injury. J. Magn. Reson. Imaging 32, 516-543.
63. Skandsen, T., Kvistad, K.A., Solheim, O., Strand, I.H., Folvik, M., and Vik, A. (2010). Prevalence and impact of diffuse axonal injury in patients with moderate and severe head injury: a cohort study of early magnetic resonance imaging findings and 1-year outcome. J. Neuro-surg. 113, 556-563.
64. Rugg-Gunn, F.J., Symms, M.R., Barker, G.J., Greenwood, R., and Duncan, J.S. (2001). Diffusion imaging shows abnormalities after blunt head trauma when conventional magnetic resonance imaging is normal. J. Neurol. Neurosurg. Psychiatry 70, 530-533.
65. Arfanakis, K., Haughton, V.M., Carew, J.D., Rogers, B.P., Dempsey, R.J., and Meyerand, M.E. (2002). Diffusion tensor MR imaging in diffuse axonal injury. Am. J. Neuroradiol. 23, 794-802.
66. Kinnunen, K.M., Greenwood, R., Powell, J.H., Leech, R., Hawkins, P.C., Bonnelle, V., Patel, M.C., Counsell, S.J., and Sharp, D.J. (2011). White matter damage and cognitive impairment after traumatic brain injury. Brain 134, 449-463.
67. Schwetye, K.E., Cirrito, J.R., Esparza, T.J., Mac Donald, C.L., Holtzman, D.M., and Brody, D.L. (2010). Traumatic brain injury reduces soluble extracellular amyloidbeta in mice: a methodologically novel combined microdialysis-controlled cortical impact study. Neu-robiol. Dis. 40, 555-564.
68. Marklund, N., and Hillered, L. (2011). Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? Br. J. Pharmacol. 164, 1207-1229.
69. Kay, A.D., Petzold, A., Kerr, M., Keir, G., Thompson, E., and Nicoll, J.A. (2003). Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. J. Neurotrauma 20, 943-952.
70. Franz, G., Beer, R., Kampfl, A., Engelhardt, K., Schmutzhard, E., Ulmer, H., and Deisenhammer, F. (2003). Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 60, 1457-1461.
71. Raby, C.A., Morganti-Kossmann, M.C., Kossmann, T., Stahel, P.F., Watson, M.D., Evans, L.M., Mehta, P.D., Spiegel, K., Kuo, Y.M., Roher, A.E., and Emmerling, M.R. (1998). Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J. Neu-rochem. 71, 2505-2509.
72. Emmerling, M.R., Morganti-Kossmann, M.C., Kossmann, T., Stahel, P.F., Watson, M.D., Evans, L.M., Mehta, P.D., Spiegel, K., Kuo, Y.M., Roher, A.E., and Raby, C.A. (2000). Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury. Ann. N. Y. Acad. Sci. 903, 118-122.
73. Magnoni, S., and Brody, D.L. (2010). New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain. Arch. Neurol. 67, 1068-1073.
74. Esparza, T.J., Zhao, H., Cirrito, J.R., Cairns, N.J., Bateman R, J., Holtzman, D.M., and Brody DL. (2013). Amyloid-b oligomerization in Alzheimer dementia versus high-pathology controls. Ann. Neurol. 73, 104-119.
75. Lachno, D.R., Emerson, J.K., Vanderstichele, H., Gonzales, C., Martényi, F., Konrad, R.J., Talbot, J.A., Lowe, S.L., Oefinger, P.E., and Dean, R.A. (2012). Validation of a multiplex assay for simultaneous quantification of amyloid-b peptide species in human plasma with utility for measurements in studies of Alzheimer's disease therapeutics. J. Alzheimers Dis. 32, 905-918.
76. Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H., Games, D., Lieberburg, I., Schenk, D., Seubert, P., and McConlogue, L. (1997). Amyloid precursor protein processing and Abeta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. 94, 1550-1555.
77. Vanderstichele, H., Van Kerschaver, E., Hesse, C., Davidsson, P., Buyse, M.A., Andreasen, N., Minthon, L., Wallin, A., Blennow, K., and Vanmechelen, E. (2000). Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 7, 245-258.
78. Bibl, M., Esselmann, H., Otto, M., Lewczuk, P., Cepek, L., Rüther, E., Kornhuber, J., and Wiltfang, J. (2004). Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides. Electrophoresis 25, 2912-2918.
79. Lachno, D.R., Vanderstichele, H., De Groote, G., Kostanjevecki, V., De Meyer, G., Siemers, E.R., Willey, M.B., Bourdage, J.S., Konrad, R.J., and Dean, R.A. (2009). The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma beta-amyloid isoforms using the INNO-BIA plasma Abeta forms multiplex assay. J. Nutr. Health Aging 13, 220-225.
80. Tanzi, R.E., Moir, R.D., and Wagner, S.L. (2004). Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 43, 605-608.
81. Bjerke, M., Portelius, E., Minthon, L., Wallin, A., Anckarsäter, H., Anckarsäter, R., Andreasen, N., Zetterberg, H., Andreasson, U., and Blennow, K. (2010). Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int. J. Alzheimers Dis. 15, 986310.
82. Schipke, C.G., Jessen, F., Teipel, S., Luckhaus, C., Wiltfang, J., Es-selmann, H., Frölich, L., Maier, W., Rüther, E., Heppner, F.L., Pro-kop, S., Heuser, I., and Peters, O. (2011). Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid. J. Alzheimers Dis. 26, 255-262.
83. Cirrito, J.R., Kang, J.E., Lee, J., Stewart, F.R., Verges, D.K., Silverio, L.M., Bu, G., Mennerick, S., and Holtzman, D.M. (2008). Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58, 42-51.
84. Kang, J.E., Cirrito, J.R., Dong, H., Csernansky, J.G., and Holtzman, D.M. (2007). Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc. Natl. Acad. Sci. 104, 10, 673-10, 678.
85. Kang, J.E., Lim, M.M., Bateman, R.J., Lee, J.J., Smyth, L.P., Cirrito, J.R., Fujiki, N., Nishino, S., and Holtzman, D.M. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007.
86. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., and Malinow, R. (2003). APP processing and synaptic function. Neuron 37, 925-937.
87. Broersen, K., Rousseau, F., and Schymkowitz, J. (2010). The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res. Ther. 2, 12.
88. Hong, S., Quintero-Monzon, O., Ostaszewski, B.L., Podlisny, D.R., Cavanaugh, W.T., Yang, T., Holtzman, D.M., Cirrito, J.R., and Selkoe, D.J. (2011). Dynamic analysis of amyloid beta-protein in behaving mice reveals opposing changes in ISF versus parenchymal Abeta during age-related plaque formation. J. Neurosci. 31, 15861-15869.